Movithiol (Betamethasone Valerate)

Betamethasone Valerate, the active ingredient in Movithiol, is a corticosteroid presented as a topical formulation for cutaneous use. It treats inflammatory skin conditions such as eczema, psoriasis, atopic dermatitis and contact dermatitis in both adults and children.

GNH USA supplies Movithiol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across all markets, and provides reliable logistics for timely delivery with dedicated technical support for product handling and regulatory documentation.

Betamethasone Valerate is a topical corticosteroid used to manage inflammatory skin disorders.

- Eczema: reduces redness, itching and swelling associated with the condition. - Atopic dermatitis: alleviates chronic inflammation and improves skin barrier function. - Psoriasis: diminishes plaque formation and scaling by suppressing local immune response. - Contact dermatitis: relieves irritation caused by allergic or irritant exposures. - Other inflammatory skin disorders: provides anti‑inflammatory relief for various dermatoses.

Topical application of Betamethasone Valerate may cause local and, rarely, systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation at the application site. - Mild skin irritation or erythema. - Dryness or peeling of the treated area. - Pruritus (itching) unrelated to the underlying disease.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Telangiectasia (visible small blood vessels) on treated skin. - Secondary bacterial, fungal or viral infection of the skin.

When prescribing or using Movithiol, consider the following precautions to minimize risks.

- Use duration: limit treatment to the shortest period necessary to control symptoms. - Surface area: avoid applying over large body surface areas unless directed by a physician. - Children: use with caution in pediatric patients; monitor for growth‑related effects. - Pre‑existing infections: do not use on skin with active bacterial, viral or fungal infections without medical supervision. - Concomitant therapy: avoid simultaneous use with other potent topical steroids unless advised. - Store at ambient temperature: keep the product in its original container, protect from moisture and direct sunlight.

Betamethasone Valerate can interact with certain medications and substances.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase risk of systemic glucocorticoid effects. - CYP3A4 inhibitors (e.g., ketoconazole): may raise local steroid concentration and enhance adverse skin reactions.

Moderate Interactions (Monitor Closely): - Antifungal or antibacterial topical agents: may alter skin absorption; monitor for irritation. - Immunosuppressants (e.g., cyclosporine): may potentiate immunosuppression, requiring clinical observation. - Phototherapy: combined use can increase risk of skin atrophy; adjust treatment schedule as needed.